Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

43 results about "Cellular Microenvironment" patented technology

BioMed Research International is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies covering a wide range of subjects in life sciences and medicine. ... The use of microfluidic systems in controlling the cellular microenvironment offers numerous advantages, such as the following ...

Method for screeing cancer metastasis inhibitor using culture of cells or spheroidically aggregated cells in which lysyl-trna synthetase is regulated to be expressed or unexpressed

InactiveUS20160146815A1Increase valueEfficient processCompound screeningApoptosis detectionAminoacyl-tRNA synthetasesHCT116 Cell
The present invention relates to a method for scanning a cancer metastasis inhibitor by analyzing the activity of lysyl-tRNA synthetase (KRS) in a cancer cell line cultured in a three-dimensional collagen gel environment, and to a method for monitoring the dissemination of cancer cells from aggregated cancer cells, and the epithelial-mesenchymal transition, migration, invasion, and metastasis of cancer cells. Specifically, it was verified that, in the case where a cell line or a spheroidically aggregated cell line, in which KRS has been regulated to be expressed or unexpressed, was constructed by using various colorectal cancer cells including HCT116 cell line and then cultured in a two-dimensional environment, the incomplete epithelial-to-mesenchymal transition phenotype (incomplete ECM phenotype) was induced in the cell line inhibiting KRS expression, and the inhibition of KRS expression inhibited cell-extracellular matrix (ECM) adhesion and cell-ECM signaling activity. In addition, it was verified that, in the case where the constructed spheroid cell line was cultured in an aqueous environment or a three-dimensional collage gel culture environment, the inhibition of KRS expression induced cells into mesenchymal cells but failed to reach the disintegration of cell-cell adhesion; inhibited the cell-ECM adhesion and the related signaling activity, causing the inhibition of the dissemination of cells from spheroid cells cultured in a three-dimensional collagen gel culture environment; and failed to induce the dissemination of cells through TGFβ1 present in the cellular microenvironment. Thus, the present invention can be used as a method for screening a cancer metastasis inhibitor and a method for monitoring the migration, invasion and metastasis of cancer cells, and will be useful as one of the screening methods capable of creating low-cost, high-efficient added value at the time of pre-clinical tests required for drug development.
Owner:MEDICINAL BIOCONVERGENCE RES CENT

Preparation method of cellular microenvironment pH-sensitive micelle

The invention discloses a preparation method of a cellular microenvironment pH-sensitive micelle. The preparation method comprises the following steps: polymerizing acrylic acid by utilizing an atom transfer radical polymerization method, thus obtaining polyacrylic acid; modifying polyacrylic acid by utilizing folic acid molecules; polymerizing O-tert-butyl-L-threonine carboxylic acid anhydride by utilizing a ring opening polymerization method, thus obtaining poly(O-tert-butyl-L-threonine); grafting adriamycin onto poly(O-tert-butyl-L-threonine) via hydrazone bonds; connecting polyacrylic acid with poly(O-tert-butyl-L-threonine) with bonds through click chemistry, thus obtaining block copolymers; after dissolving the block copolymers in tetrahydrofuran respectively, transferring the solutions into a dialysis bag, dialyzing the solutions with pure water, and filtering the dialysate with a filter membrane; freeze-drying the solutions after filtration, thus obtaining a drug loading micelle. The drug carrier micelle has a core/shell double-layer structure, wherein the outer layer is formed by hydrophilic polyacrylic acid, and the inner layer is a drug molecule coated layer. The material has the advantages that the material belongs to nanoparticles; the drug can achieve targeting delivery of cancer cells and pH-sensitive release in the cancer cells; the material has high drug loading capacity and good stability; the toxic and side effects of the drug on normal tissues and organs can be effectively reduced via the targeting function of the drug.
Owner:CHENGDU LVKE HUATONG TECH

Active oxygen content automatic detection system suitable for cell microenvironment

The invention relates to a biochemical detection instrument. The invention aims to provide a rapid, accurate and automatic detection system for realizing the trace volume of a large number of ROS content samples aiming at cell, tissue and organ microenvironments such as pleural fluid, peritoneal fluid, cerebrospinal fluid, amniotic fluid, follicular fluid, cell culture fluid and the like. The technical scheme is as follows: the active oxygen content automatic detection system suitable for a cell microenvironment is characterized in that the automatic detection system comprises a sample transmission reaction system, a detection system, a washing system communicated with the sample transmission reaction system through a water pipe pipeline and a purging system communicated with the sample transmission reaction system through an air pipe pipeline, wherein the sample transmission reaction system and the detection system are sequentially communicated through a light shielding pipeline; thesample transmission reaction system comprises a sample injector and a DCFH supply bin which are connected in parallel and then communicated with a reaction bin through a light shielding pipeline; andsample injection valves are respectively arranged between the sample injector and the reaction bin and between the DCFH supply bin and the reaction bin.
Owner:ZHEJIANG UNIV

Ac-SDKP-LDH nanocrystallization preparation as well as preparation method and application thereof

The invention discloses an Ac-SDKP-LDH nanocrystallization preparation as well as a preparation method and application thereof. The Ac-SDKP-LDH nanocrystallization preparation comprises LDH and Ac-SDKP inserted between LDH layers and is prepared through the following steps that the LDH and the Ac-SDKP are fully mixed and react at the temperature of 2-8 DEG C for 8-24 h, the Ac-SDKP is inserted between the LDH layers through ion exchange, and the Ac-SDKP-LDH nanocrystallization preparation is obtained. The Ac-SDKP-LDH nanocrystallization preparation disclosed by the invention can be used for preparing anti-silicofibrosis medicines. The method for preparing the Ac-SDKP-LDH nanocrystallization preparation is simple and easy to operate, and according to the prepared Ac-SDKP-LDH nanocrystallization preparation, under the action of a cell microenvironment, a cationic laminate of LDH dissolves in inorganic metal ions, so that the Ac-SDKP is released, the effect of protecting the Ac-SDKP is achieved, the anti-EMT effect can be sufficiently exerted, and the Ac-SDKP-LDH nanocrystallization preparation is used for preventing and treating silicosis fibrosis and has the medicine controlled release characteristics of long lasting time, high biological safety and pH sensitivity. In addition, the LDH has a certain anti-fibrosis effect, and the anti-fibrosis effect of the LDH is enhanced by compounding the LDH and the Ac-SDKP.
Owner:复旦大学附属中山医院青浦分院
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products